ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,040.53
      -0.50%
      US Tech 100
      20,518.80
      -1.78%
      Dow Jones
      44,544.66
      0.00%
      Brent Oil
      76.815
      0.60%
      Bitcoin
      95,171.37
      -2.59%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Australia
      5. ASX

      6. Australian Clinical Labs Limited (ACL) Quote

      Australian Clinical Labs Limited

      Australian Clinical Labs Limited (ACL)

      ASX
      3.79
      0.04
      (1.07%)
      Closed February 03 12:00AM
      Delayed by 20 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      3.79
      Bid
      3.77
      Ask
      3.80
      Volume
      307,243
      3.71 Day's Range 3.79
      2.14 52 Week Range 3.855
      Market Cap
      764.951M
      Previous Close
      3.75
      Open
      3.71
      Last Trade
      2139
      @
      3.78
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      530,246
      Shares Outstanding
      201,834,015
      Dividend Yield
      -
      PE Ratio
      31.96
      Earnings Per Share (EPS)
      0.12
      Revenue
      697.54M
      Net Profit
      23.93M

      About Australian Clinical Labs Limited

      Sector
      Medical Laboratories
      Industry
      Medical Laboratories
      Website
      clinicallabs.com.au/offer
      Headquarters
      Melbourne, Victoria, Aus
      Founded
      -
      Australian Clinical Labs Limited is listed in the Medical Laboratories sector of the Australian Stock Exchange with ticker ACL. The last closing price for Australian Clinical Labs was AUD3.75. Over the last year, Australian Clinical Labs shares have traded in a share price range of AUD 2.14 to AUD 3.855.

      Australian Clinical Labs currently has 201,834,015 shares outstanding. The market capitalization of Australian Clinical Labs is AUD756.88 million. Australian Clinical Labs has a price to earnings ratio (PE ratio) of 31.96.

      Ask ADVFN Intelligence (AI)

      ACL Latest News

      More News

      Alchemia Limited slammed 53%: Is the stock a buy?

      http://www.fool.com.au/2015/05/29/alchemia-limited-slammed-53-is-the-stock-a-buy/

      May 29 2015
      The Motley Fool

      Alchemia Announces Initiation of Phase II Trial in Small Cell Lung Cancer

      Alchemia Limited (ASX:ACL), today announced the initiation of recruitment for a Phase II clinical study of its lead cancer drug HA-Irinotecan in Small Cell Lung Cancer (SCLC...

      September 12 2011
      Business Wire

      UPDATE: Dr Reddy's Gets US OK For Generic Anticlotting Injection

      Dr. Reddy's Laboratories Ltd. (500124.BY) said Wednesday it has received U.S. regulatory approval to launch a copy of GlaxoSmithKline PLC's (GSK) anticlotting Arixtra injection, which is expected...

      July 13 2011
      Dow Jones News

      Dr. Reddy’s Announces the USFDA Approval of Fondaparinux Sodium Injection

      Dr. Reddy’s Laboratories (NYSE: RDY) and Alchemia Limited, Brisbane, Australia (ASX: ACL) announced today that Dr. Reddy’s has received final approval of Dr. Reddy’s ANDA for...

      July 13 2011
      Business Wire

      Dr Reddy's Gets US OK To Sell Generic Injection To Prevent Blood Clots

      Dr. Reddy's Laboratories Ltd. (500124.BY) said Wednesday it has received final approval from the U.S. Food and Drug Administration to sell a generic version of GlaxoSmithKline PLC's (GSK) Arixtra...

      July 13 2011
      Dow Jones News

      Alchemia to Present at Cowen and Company 31st Annual Health Care Conference

      Alchemia Limited (ASX: ACL) announced today that Pete Smith, Chief Executive Officer, is scheduled to present a corporate update at the Cowen and Company 31st Annual Health Care...

      March 04 2011
      Business Wire

      Alchemia and Dr Reddy’s Expand Fondaparinux Marketing Collaboration

      Alchemia (ASX:ACL) today announced the agreement of terms with Dr Reddy’s Limited for marketing fondaparinux sodium for injection (the generic version of GlaxoSmithKline’s...

      July 14 2010
      Business Wire

      Alchemia’s HyACT Technology Enhances the Killing of Cancer Stem Cell Populations in Breast and Colorectal Cancer

      Alchemia’s (ASX: ACL) subsidiary Alchemia Oncology today presented two posters at the American Association of Cancer Research (AACR) 101st Annual Meeting in Washington, DC. The...

      April 20 2010
      Business Wire

      Emisphere Technologies and Alchemia to Research an Oral Formulation of Fondaparinux with Eligen® Technology

      Emisphere Technologies, Inc. (OTCBB:EMIS) and Alchemia Ltd. (ASX:ACL) today announced that they are joining efforts to develop an oral formulation of the anti-coagulant drug...

      March 18 2010
      Business Wire

      CORRECT: Alcon 3Q Profit Down 18%, Raises 2009 Earnings View

      ("Alcon 3Q Profit Down 18%, Raises 2009 Earnings View 2nd Time," published at 6:12 p.m. EDT, incorrectly included a tax benefit for the latest quarter. The correct version follows.) DOW JONES...

      October 27 2009
      Dow Jones News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.246.760563380283.553.793.536035633.66610718DE
      40.4312.79761904763.363.793.324945693.50392706DE
      120.246.760563380283.553.83.295302463.50473154DE
      261.2348.0468752.563.8552.388472193.3854588DE
      520.7625.08250825083.033.8552.147946152.96592668DE
      156-1.22-24.35129740525.015.882.147033113.49409658DE
      2603.77934354.54545450.0116.390.0116977943.65177537DE

      ACL - Frequently Asked Questions (FAQ)

      What is the current Australian Clinical Labs share price?
      The current share price of Australian Clinical Labs is AUD 3.79
      How many Australian Clinical Labs shares are in issue?
      Australian Clinical Labs has 201,834,015 shares in issue
      What is the market cap of Australian Clinical Labs?
      The market capitalisation of Australian Clinical Labs is AUD 756.88M
      What is the 1 year trading range for Australian Clinical Labs share price?
      Australian Clinical Labs has traded in the range of AUD 2.14 to AUD 3.855 during the past year
      What is the PE ratio of Australian Clinical Labs?
      The price to earnings ratio of Australian Clinical Labs is 31.96
      What is the cash to sales ratio of Australian Clinical Labs?
      The cash to sales ratio of Australian Clinical Labs is 1.1
      What is the reporting currency for Australian Clinical Labs?
      Australian Clinical Labs reports financial results in AUD
      What is the latest annual turnover for Australian Clinical Labs?
      The latest annual turnover of Australian Clinical Labs is AUD 697.54M
      What is the latest annual profit for Australian Clinical Labs?
      The latest annual profit of Australian Clinical Labs is AUD 23.93M
      What is the registered address of Australian Clinical Labs?
      The registered address for Australian Clinical Labs is 1868-1892 DANDENONG ROAD, CLAYTON, MELBOURNE, VICTORIA, 3168
      What is the Australian Clinical Labs website address?
      The website address for Australian Clinical Labs is clinicallabs.com.au/offer
      Which industry sector does Australian Clinical Labs operate in?
      Australian Clinical Labs operates in the MEDICAL LABORATORIES sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      OZMOzAurum Resources Limited
      AUD 0.06
      (76.47%)
      		59.01M
      MGUOMagnum Mining and Exploration Ltd
      AUD 0.003
      (50.00%)
      		641.91k
      EXTODExcite Technology Services Ltd
      AUD 0.003
      (50.00%)
      		25.5M
      NOUONoumi Ltd
      AUD 0.01
      (42.86%)
      		1.38k
      PHLPropell Holdings Limited
      AUD 0.021
      (40.00%)
      		94
      RAGODRagnar Metals Limited
      AUD 0.002
      (-60.00%)
      		5M
      HWKOAHawk Resources Ltd
      AUD 0.001
      (-50.00%)
      		62.5k
      AMSAtomos Limited
      AUD 0.004
      (-42.86%)
      		28.08M
      LNULinius Technologies Limited
      AUD 0.001
      (-33.33%)
      		5.74M
      EELENRG Elements Ltd
      AUD 0.001
      (-33.33%)
      		2.12M
      ATHAlterity Therapeutics Ltd
      AUD 0.014
      (21.74%)
      		102.71M
      OZMOzAurum Resources Limited
      AUD 0.06
      (76.47%)
      		59.01M
      SYASayona Mining Limited
      AUD 0.022
      (-4.35%)
      		56.73M
      NRZNeuRizer Ltd
      AUD 0.002
      (0.00%)
      		55.19M
      NMGNew Murchison Gold Ltd
      AUD 0.011
      (10.00%)
      		49.49M

      Discussion

      View Full Feed
      AMB67 AMB67 50 seconds ago
      Speak for yourself. Also, you should sell your supposed 1.5M position.
      RDGL
      Controlledoilandgas Controlledoilandgas 53 seconds ago
      We intend to uplist to QX not QB. We will begin the audit after the Button merger so that we are auditing once and not twice. We except to being the audit March 15-30th which will allow us sufficient time to fully integrate the merger and ensure we are fully prepared for the audit, less so on financ
      AZRH
      SamuraiAstronaut68 SamuraiAstronaut68 54 seconds ago
      The burgeoning field of cryptocurrencies has significantly altered the landscape of personal finance, offering an alternative to traditional banking systems for savings and investment. Many individuals are drawn to the decentralized nature of cryptocurrencies and the potential for high returns, lead
      NWBO
      glenn1919 glenn1919 2 minutes ago
      RIME......BHAT......UOKA......MULN............................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=3&dy=0&id=p11960084343
      BHAT MULN UOKA
      Chiron Chiron 3 minutes ago
      BUY
      ASII
      glenn1919 glenn1919 3 minutes ago
      BHAT.......RIME.......PRPH........MULN.............................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=3&dy=0&id=p11960084343
      BHAT MULN PRPH
      sab63090 sab63090 4 minutes ago
      Yeah, I guess the iHub guys going to the cloud still have not corrected the duplicate posts....lol
      AVXL
      Zardiw Zardiw 4 minutes ago
      Why I love $TORVF:

      1. Their CEO is a mini version of Elon Musk

      2. They have massive Graphite mining claims, which are up to 80% pure.

      3. Their Air Qualifier for Graphite is a technological revolution in Graphite Production.

      --- And it ha
      TORVF
      resx18 resx18 5 minutes ago
      Good Morning $CBDW
      CBDW
      sab63090 sab63090 5 minutes ago
      Yeah, I've been caught quite a few times in going to one side of the boat!

      When things get tough we all share the same FEAR, but somehow the market fools most of us!
      AVXL
      LTListener LTListener 5 minutes ago
      Interesting that at this conference they are using the subsidiary name Endeavourrx versus RespireRx. Granted we are all still starving for updates, but this could lend more credence to the idea that they are indeed spinning out the neuromodulator division as they have been suggesting for several ye
      RSPI
      RIGATONI RIGATONI 5 minutes ago
      Did you look at this? added ~Rig
      extrinsic55 extrinsic55 6 minutes ago
      SPXS ask 6.12 ClimbContinuesFromFriday
      SPXS
      Zardiw Zardiw 6 minutes ago
      Why I love $TORVF:

      1. Their CEO is a mini version of Elon Musk

      2. They have massive Graphite mining claims, which are up to 80% pure.

      3. Their Air Qualifier for Graphite is a technological revolution in Graphite Production.

      --- And it ha
      TORVF
      trunkmonk trunkmonk 6 minutes ago
      New estimate by Forbes, XRP could go to $60k.
      XRPUSD
      Zardiw Zardiw 6 minutes ago
      Why I love $TORVF:

      1. Their CEO is a mini version of Elon Musk

      2. They have massive Graphite mining claims, which are up to 80% pure.

      3. Their Air Qualifier for Graphite is a technological revolution in Graphite Production.

      --- And it ha
      TORVF
      extrinsic55 extrinsic55 6 minutes ago
      SPXS ask 6.12 ClimbContinuesFromFriday
      SPXS
      jammy32 jammy32 6 minutes ago
      How bad does the tariff hit portillo
      PTLO
      cottonmather cottonmather 7 minutes ago
      Because of Trump the farm partnership I am part of has been asked to increase production of some produce we grow, ASAP. The government contends a 110 mile shift south will satisfy most needs - not true in our case. When I said Trump was fukking up everything I meant EVERYTHING. One of the beautie
      extrinsic55 extrinsic55 7 minutes ago
      UVXY ask 21.26 ClimbContinuesVIXrising
      UVXY
      MightyX MightyX 8 minutes ago
      Y’all bargained the communication control..no pitty points
      TPTW
      glenn1919 glenn1919 8 minutes ago
      SOPA.......TCTM....BHAT.....REBN........MULN............................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=3&dy=0&id=p11960084343
      BHAT MULN REBN
      extrinsic55 extrinsic55 8 minutes ago
      UVXY ask 21.26 ClimbContinuesVIXrising
      UVXY
      tw0122 tw0122 8 minutes ago
      Alzheimer's reduced inflammation...INM $3.35 +10% with that 500k float can pop it ant day maybe today..lol
      INM
      RIGATONI RIGATONI 9 minutes ago
      Nice piece of news...

      for the potential pop trade

      INM $3.36

      https://finance.yahoo.com/news/inmed-announces-inm-089-intravitreal-123000105.html
      INM

      Your Recent History

      ASX
      ACL
      Australian Clinical Labs
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads